I pose the question of... when to run.....
The phase2 results for 1503 being inconclusive from a medical standpoint.
Who will stand or run if the same thing were to occur using 1204. The phase 1b result from 1204 looked even better from a results point of view than the 1503 looked... so if they both failed to replicate the same results in phase 2..... thats 2 from 2 and i think im out.
For that to occur, the initial hype or results must have been overstated somehow if they subsequently consistently miss the mark moving into the next phase.
Of course if 1204 performs as expected.... as it did in phase 1b..... I'll be here for the 50 cent party..
what do others think?
I pose the question of... when to run.....The phase2 results for...
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.0¢ | $1.603M | 4.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 378157 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 98000 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |